Cargando…
Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment
BACKGROUND: Hepatitis B virus (HBV) is one of the most prominent risk factors for hepatocellular carcinoma (HCC) development and virus-mediated cases represents more than 80% of HCC in East Asia, where it is endemic. Currently, the HBV status of pathological HCC is not fully clarified, especially by...
Autores principales: | Liu, Jiao, Chen, Siyuan, Zou, Zhe, Tan, Dehong, Liu, Xiangde, Wang, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581976/ https://www.ncbi.nlm.nih.gov/pubmed/31202090 http://dx.doi.org/10.1016/j.tranon.2019.05.006 |
Ejemplares similares
-
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2020) -
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
por: Hu, Zili, et al.
Publicado: (2022) -
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021) -
MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014) -
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
por: Villeret, François, et al.
Publicado: (2023)